Association of the interferon-gamma single nucleotide polymorphism +874(T/A) with response to immunosuppressive therapy in patients with severe aplastic anemia

Blood Cells, Molecules, and Diseases

Volumn 45, Issue 4, 2010, Pages 313-316

  Chang, Hong ^a   Zeng, Fan ^a   Zhang, Jia You ^a   Mu, Xiao Yan ^a   Meng, Wen Tong ^a   Ma, Hong Bing ^a   Liu, Ting ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Aplastic anemia; Immunosuppressive therapy; Interferon ; Single nucleotide polymorphisms

Indexed keywords

CYCLOSPORIN A; GAMMA INTERFERON; LYMPHOCYTE ANTIBODY; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; AGED; APLASTIC ANEMIA; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; GENE LOCATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC CORRELATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; AGED; AGED, 80 AND OVER; ANEMIA, APLASTIC; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-GAMMA; MALE; MIDDLE AGED; PHARMACOGENETICS; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 78649443778     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2010.09.003     Document Type: Article

References (11)

1. Frickhofen N., Heimpel H., Kaltwasser J.P., Schrezenmeier H. Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia. Blood 2003, 101:1236-1242.
2. Rosenfeld S., Follmann D., Nunez O., Young N.S. Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome. JAMA 2003, 289:1130-1135.
3. Pravica V., Perrey C., Stevens A., Lee J.H., Hutchinson I.V. A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Hum. Immunol. 2000, 61:863-866.
4. Rosenfeld S.J., Kimball J., Vining D., Young N.S. Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia. Blood 1995, 85:3058-3065.
5. Young N.S., Calado R.T., Scheinberg P. Current concepts in the pathophysiology and treatment of aplastic anemia. Blood 2006, 108:2509-2519.
6. Young N.S. Etiology of acquired aplastic anemia. Rev. C lin. Exp. Hematol. 2000, 4:236-259.
7. Platanias L.C. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat. Rev. Immunol. 2005, 5:375-386.
8. Zeng W., Miyazato A., Chen G., Kajigaya S., Young N.S., Maciejewski J.P. Interferon-gamma-induced gene expression in CD34 cells: identification of pathologic cytokine-specific signature profiles. Blood 2006, 107:167-175.
9. Dufour C., Capasso M., Svahn J., Marrone A., Haupt R., Bacigalupo A., Giordani L., Longoni D., Pillon M., Pistorio A., Di Michele P., Iori A.P., Pongiglione C., Lanciotti M., Iolascon A. Homozygosis for (12) CA repeats in the first intron of the human IFN-gamma gene is significantly associated with the risk of aplastic anaemia in Caucasian population. Br. J. Haematol. 2004, 126:682-685.
10. Biolo G., Amoroso A., Savoldi S., Bosutti A., Martone M., Pirulli D., Bianco F., Ulivi S., Bertok S., Artero M., Barazzoni R., Zanetti M., Grassi G., Guarnieri G., Panzetta G. Association of interferon-gamma +874A polymorphism with reduced long-term inflammatory response in haemodialysis patients. Nephrol. Dial. Transplant. 2006, 21:1317-1322.
11. Sloand E., Kim S., Maciejewski J.P., Tisdale J., Follmann D., Young N.S. Intracellular interferon-gamma in circulating and marrow T cells detected by flow cytometry and the response to immunosuppressive therapy in patients with aplastic anemia. Blood 2002, 100:1185-1191.